Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B

World J Gastroenterol. 2001 Jun;7(3):407-10. doi: 10.3748/wjg.v7.i3.407.

Authors

L Zhuang¹, J You, B Z Tang, S Y Ding, K H Yan, D Peng, Y M Zhang, L Zhang

Affiliation

¹ Department of Hepatology, Kunming Third Municipal People's Hospital, 319 Wu Jin Road, Kunming 650041,Yunnan Province, China.

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Adjuvants, Immunologic / administration & dosage*
Adolescent
Adult
Alanine Transaminase / blood
Antiviral Agents / administration & dosage*
DNA, Viral / analysis
Follow-Up Studies
Hepatitis B e Antigens / blood
Hepatitis B virus / genetics
Hepatitis B virus / isolation & purification*
Hepatitis B, Chronic / drug therapy*
Humans
Interferon-alpha / administration & dosage*
Middle Aged
Thymalfasin
Thymosin / administration & dosage*
Thymosin / analogs & derivatives*

Substances

Adjuvants, Immunologic
Antiviral Agents
DNA, Viral
Hepatitis B e Antigens
Interferon-alpha
Thymosin
Alanine Transaminase
Thymalfasin